[HTML][HTML] MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets
S Liu, M Fan, Q Zheng, S Hao, L Yang, Q Xia… - Biomedicine & …, 2022 - Elsevier
Alzheimer's disease (AD) is the most common neurodegenerative disease, with cognitive
decline as the primary clinical feature. According to epidemiological statistics, 50 million …
decline as the primary clinical feature. According to epidemiological statistics, 50 million …
MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets
S Liu, M Fan, Q Zheng, S Hao… - Biomedicine & …, 2022 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the most common neurodegenerative disease, with cognitive
decline as the primary clinical feature. According to epidemiological statistics, 50 million …
decline as the primary clinical feature. According to epidemiological statistics, 50 million …
MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets.
S Liu, M Fan, Q Zheng, S Hao, L Yang… - Biomedicine & …, 2022 - europepmc.org
Alzheimer's disease (AD) is the most common neurodegenerative disease, with cognitive
decline as the primary clinical feature. According to epidemiological statistics, 50 million …
decline as the primary clinical feature. According to epidemiological statistics, 50 million …